Eurofins Global Central Laboratory opens new Central Laboratory in Bangalore, India
Eurofins Global Central Laboratory announced that is has achieved an important strategic milestone with the opening of a new Central Laboratory in Bangalore, India. This new laboratory complements the Eurofins Global Central Laboratory current global footprint of wholly-owned laboratory facilities in the United States, Europe, Singapore, and China.
René van Erp, Managing Director Eurofins Global Central Laboratory, explains: “Eurofins Global Central Laboratory is uniquely positioned since only few Contract Research Organizations (CROs) offer a similar global footprint. This expansion of our global footprint allows us to bring more value to our customers, and makes Eurofins Global Central Laboratory a unique world-wide source for laboratory testing in clinical trials.”
Located in Bangalore, known as the Knowledge Hub in India, the facility will operate congruently to the other Eurofins Central Laboratory locations. Successfully operational since the 1st of September, the Bangalore central laboratory facility offers a full package of safety testing, as well as biomarker testing. Upon its launch, the facility is certified with the National Glycohemoglobin Standardization Program (NGSP) Level 1 accreditation, and should achieve NABL and CAP accreditations within its first year of operation. The Bangalore facility’s location gives it easy access to the transportation infrastructure in India, enabling close control over transportation and maintenance of specimen integrity.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
